Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study to track Long-Term effects of Gender-Affirming care on 1,000 adults

NCT ID NCT07171645

Knowledge-focused Sponsor: Region Skane Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Nov 01, 2025

Summary

This study will follow 1,000 adults seeking gender-affirming care to see how their mental health, quality of life, and ability to work change over time. Researchers will also compare them to a similar group not receiving this care. The goal is to understand what helps people the most and to reduce stigma.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Aug 2032

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adults (18 years and older) diagnosed with gender dysphoria who have been referred to the National Highly Specialized Care (NHV) Unit for gender dysphoria at Region Skåne. This clinic is one of Sweden's national centers for gender-affirming care, receiving approximately 350-400 new referrals annually. Participants are enrolled at the start of their initial clinical assessment, which is the gateway to potential interventions such as hormone therapy, surgery, voice therapy, and psychological support. The study includes individuals of all gender identities (e.g., female, male, nonbinary) to reflect the diversity of the transgender population. Participants are followed longitudinally using self-report questionnaires, clinical records, and national registry data to assess mental health, identity development, and quality-of-life outcomes across time.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Individuals aged 18 years and older. Referred to the National Highly Specialized Care Unit (NHV) for gender dysphoria at Region Skåne. Presenting for initial clinical assessment for gender-affirming care. Able to provide informed consent for participation in the self-report portion of the study. Participants may identify as female, male, or another gender identity. Exclusion Criteria: Inability to read or write Swedish, as all self-report measures and consent forms are in Swedish. Individuals with protected (secret) identities, such as those under special confidentiality protections or in high-security identity protection programs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gender dysphoria, adult are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gender Dysphoria Social Stigma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gender dysphoria, adult Psychiatric comorbidities

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department/Office of Psychiatry, National specialized medical care, Skåne University Hospital, Lund, Sweden.

    Lund, Skåne County, 22185, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.